Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

In a first for the U.S., Utah is letting artificial intelligence — not a doctor — renew certain medical prescriptions. No ...

Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.

While Walz issued press statements specifying the policy and administrative decisions he has made to tackle fraud, and has ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...

DHS said the man was convicted of three counts of assault, two firearm-related felonies, and concealing and receiving a ...

Edge devices across multiple applications share common attack vectors. Security functionality must be designed in from the ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor.  This approach enabled them to ...